학술논문

Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
Document Type
Brief Communication
Source
Nature Medicine. 29(6):1310-1312
Subject
Language
English
ISSN
1078-8956
1546-170X
Abstract
Individuals with cutaneous melanoma who are treated with neoadjuvant immunotherapy show a substantial improvement; this should be incorporated into standard care.